Here’s How Amgen May Help Merck

Amgen (NASDAQ: AMGN  ) is working on a new cholesterol-busting drug that may reinvent how doctors attack cardiovascular disease. The company’s AMG-145, also known as evolocumab, could be on its...

Better Buy: Enterprise Products Partners vs. Amgen

We’ve collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we’re calling The Motley Fool Better-Buy Tournament. In tod...

[video] Analyst likes large cap biotechs

President Obama addresses tech privacy Fri 21 Mar 14 | 04:12 PM Playing potential EU nat gas plan Fri 21 Mar 14 | 04:07 PM Luxury brand stocks could come relatively cheap Fri 21 Mar 14 | 04:00 PM Com...